Search research articles
Contact Us
Filters
Showing results (91-100 of 108) with videos related to
Page
of 11
Sort By:
The Journal of Infectious Diseases
|
August 2, 2012
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium
Susan E Dorman, Stefan Goldberg, Jason E Stout, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 16, 2019
MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by Mycobacteria
Sara Suliman, Melissa Murphy, Munyaradzi Musvosvi, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 2, 2009
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis
Susan E Dorman, John L Johnson, Stefan Goldberg, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 10, 2014
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial
Susan E Dorman, Radojka M Savic, Stefan Goldberg, et al.
JCI Insight
|
February 8, 2024
Gene coexpression networks reveal a broad role for lncRNAs in inflammatory bowel disease
John L Johnson, Davit Sargsyan, Eric M Neiman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa
Walter O Mwanda, Jackson Orem, Pingfu Fu, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 9, 2011
CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap
Payam Nahid, Jussi Saukkonen, William R Mac Kenzie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 30, 2022
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349)
April C Pettit, Patrick P J Phillips, Ekaterina Kurbatova, et al.
Plos Pathogens
|
November 18, 2017
Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease
Thomas J Scriba, Adam Penn-Nicholson, Smitha Shankar, et al.
Ebiomedicine
|
February 12, 2022
Effects of BCG vaccination on donor unrestricted T cells in two prospective cohort studies
Anele Gela, Melissa Murphy, Miguel Rodo, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 108) with videos related to
Sort By:
Page
of 11
The Journal of Infectious Diseases
|
August 2, 2012
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium
Susan E Dorman, Stefan Goldberg, Jason E Stout, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 16, 2019
MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by Mycobacteria
Sara Suliman, Melissa Murphy, Munyaradzi Musvosvi, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 2, 2009
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis
Susan E Dorman, John L Johnson, Stefan Goldberg, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 10, 2014
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial
Susan E Dorman, Radojka M Savic, Stefan Goldberg, et al.
JCI Insight
|
February 8, 2024
Gene coexpression networks reveal a broad role for lncRNAs in inflammatory bowel disease
John L Johnson, Davit Sargsyan, Eric M Neiman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa
Walter O Mwanda, Jackson Orem, Pingfu Fu, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 9, 2011
CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap
Payam Nahid, Jussi Saukkonen, William R Mac Kenzie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 30, 2022
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349)
April C Pettit, Patrick P J Phillips, Ekaterina Kurbatova, et al.
Plos Pathogens
|
November 18, 2017
Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease
Thomas J Scriba, Adam Penn-Nicholson, Smitha Shankar, et al.
Ebiomedicine
|
February 12, 2022
Effects of BCG vaccination on donor unrestricted T cells in two prospective cohort studies
Anele Gela, Melissa Murphy, Miguel Rodo, et al.
Page
of 11